BELOGENT

This brand name is authorized in Croatia, Poland, Turkey

Active ingredients

The drug BELOGENT contains a combination of these active pharmaceutical ingredients (APIs):

1 Betamethasone UNII 826Y60901U - BETAMETHASONE DIPROPIONATE

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. Read about Betamethasone

2 Gentamicin UNII 8X7386QRLV - GENTAMICIN SULFATE

Gentamicin is usually bactericidal in action. Although the exact mechanism of action has not been fully elucidated, the drug appears to inhibit protein synthesis in susceptible bacteria by irreversibly binding to 30S ribosomal subunits. Read about Gentamicin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D07CC01	Betamethasone and antibiotics	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07C Corticosteroids, combinations with antibiotics → D07CC Corticosteroids, potent, combinations with antibiotics
Discover more medicines within D07CC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-522868743, HR-H-548868989
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100135270, 100135292, 100395490, 100402497, 100403924, 100413992, 100417300, 100417317, 100418890, 100468346
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699738350567, 8699738350581, 8699738380601, 8699738380618